Annual Updates from ASH 2017: Practice Changing Abstracts
At the conclusion of this activity, participants will be able to:
- Cite how understanding the biology of different types of leukemia has influenced treatment approaches;
- Describe next generation improvements in CAR T-cell therapies;
- Identify methods for integrating therapeutic advances into practice to improve current myeloma patient care;
- List current best practices in first and second line therapies for lymphoid malignancies;
- Name new technologies used for the treatment of hemophilia;
- Interpret how new scientific insights are informing the diagnosis and treatment of myelodysplastic syndromes and myeloproliferative neoplasms.
Click here for more information on the Knapp Center for Biomedical Discovery!
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 219-465-1115 or via email at email@example.com.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
Professor of Medicine
Director, Hematopoietic Stem Cell Transplantation Program
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.